Literature DB >> 27765688

Drug-Induced Liver Injury in Patients With Preexisting Chronic Liver Disease in Drug Development: How to Identify and Manage?

Naga Chalasani1, Arie Regev2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27765688     DOI： 10.1053/j.gastro.2016.10.010

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  14 in total

Review 1.  Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

2.  Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study.

Authors:  Jean-Luc Szpakowski; Lue-Yen Tucker; David M Baer; Mary Pat Pauly
Journal:  Can Liver J       Date:  2022-02-04

3.  Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring.

Authors:  Hani Shamseddeen; Eduardo Vilar-Gomez; Naga Chalasani; Robert P Myers; G Mani Subramanian; Harold H Shlevin; Adam E Allgood; Eric S Orman
Journal:  Drug Saf       Date:  2020-03       Impact factor: 5.606

4.  A retrospective case-controlled cohort study of inpatient drug induced liver injury: the RIDDLE study.

Authors:  Thomas Worland; Ken Lee Chin; Beverley Rodrigues; Amanda Nicoll
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 5.  Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.

Authors:  Arie Regev; Melissa Palmer; Mark I Avigan; Lara Dimick-Santos; William R Treem; John F Marcinak; Daniel Seekins; Gopal Krishna; Frank A Anania; James W Freston; James H Lewis; Arun J Sanyal; Naga Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2019-02-13       Impact factor: 8.171

6.  Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration.

Authors:  Xiaohe Xiao; Jianyuan Tang; Yimin Mao; Xiuhui Li; Jiabo Wang; Chenghai Liu; Kewei Sun; Yong'an Ye; Zhengsheng Zou; Cheng Peng; Ling Yang; Yuming Guo; Zhaofang Bai; Tingting He; Jing Jing; Fengyi Li; Na An
Journal:  Acta Pharm Sin B       Date:  2018-12-14       Impact factor: 11.413

7.  Retrospective study of idiosyncratic drug-induced liver injury from infliximab in an inflammatory bowel disease cohort: the IDLE study.

Authors:  Thomas Worland; Ken Lee Chin; Daniel van Langenberg; Mayur Garg; Amanda Nicoll
Journal:  Ann Gastroenterol       Date:  2020-02-12

Review 8.  Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.

Authors:  Melissa Palmer; Arie Regev; Keith Lindor; Mark I Avigan; Lara Dimick-Santos; William Treem; John F Marcinak; James H Lewis; Frank A Anania; Daniel Seekins; Benjamin L Shneider; Naga Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2019-11-25       Impact factor: 8.171

9.  Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome.

Authors:  Benjamin L Shneider; Cathie Spino; Binita M Kamath; John C Magee; Lee M Bass; Kenneth D Setchell; Alexander Miethke; Jean P Molleston; Cara L Mack; Robert H Squires; Karen F Murray; Kathleen M Loomes; Philip Rosenthal; Saul J Karpen; Daniel H Leung; Stephen L Guthery; Danny Thomas; Averell H Sherker; Ronald J Sokol
Journal:  Hepatol Commun       Date:  2018-09-24

10.  Evaluation of Drug-Induced Liver Injury Developed During Hospitalization Using Electronic Health Record (EHR)-Based Algorithm.

Authors:  Yewon Kang; Sae Hoon Kim; So Young Park; Bo Young Park; Ji Hyang Lee; Jin An; Ha Kyeong Won; Woo Jung Song; Hyouk Soo Kwon; You Sook Cho; Hee Bom Moon; Ju Hyun Shim; Min Suk Yang; Tae Bum Kim
Journal:  Allergy Asthma Immunol Res       Date:  2020-05       Impact factor: 5.764
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.